You are here

  • Home
  • Archive
  • Volume 66, Issue 7
  • Strong expression of the neuronal transcription factor FOXP2 is linked to an increased risk of early PSA recurrence in ERG fusion-negative cancers

Article info

Article menu

Download PDFPDF

Original article
Strong expression of the neuronal transcription factor FOXP2 is linked to an increased risk of early PSA recurrence in ERG fusion-negative cancers
Free

Authors

  1. Correspondence to Uwe Michl, Martini-Clinic, Prostate Cancer Center, University Medical Center, 20246, Hamburg-Eppendorf, Germany; michl{at}uke.de
View Full Text

Citation

Stumm L, Burkhardt L, Steurer S, et al
Strong expression of the neuronal transcription factor FOXP2 is linked to an increased risk of early PSA recurrence in ERG fusion-negative cancers
Journal of Clinical Pathology 2013;66:563-568.

Publication history

  • Received November 6, 2012
  • Revised December 31, 2012
  • Accepted February 4, 2013
  • First published April 4, 2013.
Online issue publication 
June 15, 2020

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions